Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,062 | 52,009 | 53,423 | 56,373 | 54,440 |
| Receivables | 108,964 | 106,934 | 110,900 | 127,041 | 121,113 |
| Inventories | 75,107 | 78,275 | 82,866 | 79,736 | 80,586 |
| TOTAL | $274,868 | $265,240 | $273,982 | $285,775 | $286,982 |
| Non-Current Assets | |||||
| PPE Net | 25,095 | 26,547 | 26,280 | 22,913 | 21,564 |
| Intangibles | 265,152 | 274,725 | 279,595 | 287,097 | 318,618 |
| Other Non-Current Assets | 63,998 | 61,488 | 58,706 | 42,355 | 26,881 |
| TOTAL | $354,245 | $362,760 | $364,581 | $352,365 | $367,063 |
| Total Assets | $629,113 | $628,000 | $638,563 | $638,140 | $654,045 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 35,000 | 35,000 | 35,000 | 35,000 | N/A |
| Accounts payable and accrued liabilities | 30,096 | 25,235 | 25,103 | 28,805 | 20,595 |
| Accrued Expenses | 56,657 | 51,605 | 51,157 | 52,568 | 52,015 |
| Other current liabilities | N/A | N/A | 24,786 | N/A | N/A |
| TOTAL | $146,896 | $137,661 | $161,314 | $133,446 | $109,426 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,618 | 44,570 | 64,522 | 69,474 | 94,426 |
| Deferred Revenues | 19,242 | 19,861 | 19,017 | 17,073 | 16,816 |
| Other Non-Current Liabilities | 33,312 | 35,563 | 36,559 | 19,845 | 21,338 |
| TOTAL | $76,059 | $88,782 | $109,548 | $106,250 | $134,660 |
| Total Liabilities | $222,955 | $226,443 | $270,862 | $239,696 | $244,086 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,090 | 34,069 | 34,006 | 33,777 | 33,781 |
| Common Shares | 341,083 | 338,735 | 335,348 | 334,215 | 331,607 |
| Retained earnings | 86,241 | 77,780 | 73,592 | 102,261 | 113,895 |
| Other shareholders' equity | -21,166 | -14,958 | -41,239 | -38,032 | -35,543 |
| TOTAL | $406,158 | $401,557 | $367,701 | $398,444 | $409,959 |
| Total Liabilities And Equity | $629,113 | $628,000 | $638,563 | $638,140 | $654,045 |